Exciting news at Psyomics! We’re delighted to announce that Dr Michelle Tempest has joined us as Non-Executive Director and Dr Melinda R. is now our permanent CEO.
After a successful 2023, the new leadership team will expedite Psyomics' ability to deliver tech-powered mental health assessments at scale. These appointments underscore our commitment to improving access to mental health services in collaboration with the public and private sectors.
Dr Tempest, a distinguished figure in Psychiatry and healthcare innovation, brings her wealth of international experience to guide the commercial development of Censeo, our pioneering mental health solution designed for mental health assessment, triage, and pathway prediction.
In her new role at Psyomics, Dr Tempest said: “I am passionate about leveraging my psychiatry experience to Psyomics' innovative approach. My focus will be on ensuring that our solutions not only meet the needs of our customers but also make a tangible difference in the lives of patients”.
Dr Rees, with a dynamic blend of leadership and a 25-year clinical career, takes the helm as CEO. Her strategic oversight has already propelled Censeo's launch across Hertfordshire Mental Health Trust, Devon, and the Midlands.
Dr Rees and Dr Tempest’s combined expertise is set to drive technological innovation, enhance clinical outcomes, and revolutionise our global approach to mental health.